GPT and metabolic dysfunction-associated steatotic liver disease: Finally, some trials have observed that statins significantly improve aminotransferase values and CV outcomes in patients with elevated ALT/AST concentrations, therefore lipid-lowering therapy is considered a standard of care for patients with NAFLD [81].